PIC-22_eCoN: Using Electrocochleography During Cochlear Implantation of the Neuro Zti.

Sponsor
Oticon Medical (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT04651660
Collaborator
(none)
20
2
12

Study Details

Study Description

Brief Summary

The main objective of this study is to evaluate the correspondence between eCochG and residual hearing by adding two modifications. First, a novel technique for placing and maintaining the probe in place during the whole insertion will be used. Second, a new metric for estimating the eCochG response will be evaluated (eCochG trauma index). The secondary objective is to find other markers of the cochlear trauma insertion associated to eCochG measures. This will be used to evaluate to which extend a traumatic insertion will be deleterious for the patient's post-operative hearing, and ultimately to prevent trauma to the inner ear. Finally, the potential differences in cochlear trauma resulting of the electrode array insertion from two different surgery techniques will be investigated; Either using a manual insertion or using a robotic arm that will drive the insertion automatically.

Condition or Disease Intervention/Treatment Phase
  • Device: Neuro Cochlear Implant System
N/A

Detailed Description

Main study procedures and assessments:
  • Visit 1 (D-30+/-14) INCLUSION: subject information/consent, inclusion/exclusion criteria, CT-scan, Tonal audiometry

  • Visit 2 (D0+/-14) COCHLEAR IMPLANT SURGERY: CT-scan, Intra-op eCochG, eCAP, Impedance

  • Visit 3 (D+30+/-14) FOLLOW-UP 1 MONTH: Tonal audiometry, Impedance, Fitting maps

  • Visit 4 (D+60+/-14) FOLLOW-UP 2 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes

  • Visit 5 (D+90+/-14) FOLLOW-UP 3 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Using Electrocochleography to Guide Insertion of the Electrode Array During Cochlear Implantation of the Neuro Zti (eCoN)
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Manual Insertion

The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole MANUAL insertion (by the surgeon).

Device: Neuro Cochlear Implant System
Before the mastoidectomy, the ear canal is cleaned, the insert earphone is connected to the Eclipse (Oticon Medical software) preamplifier and placed into the ear canal. The EEG scalp electrodes (active, ground electrode) are placed on the patient's head. After the posterior tympanotomy, the reference electrode (eCochG probe) is placed on the cochlear promontory. The CI electrode array will be inserted following one of the two possible techniques while the eCochG will be recording. The surgeon will either manually insert the array using the Oticon Medical stylet and following the surgery guides and recommendations from Oticon Medical or will control the Robotol insertion angle and drive the robotic arm in the same way.

Experimental: Robotic insertion

The surgeon will follow a classical surgical procedure for the cochlear implantation, i.e. mastoidectomy to access the temporal bone, posterior tympanotomy to access the cochlea and round window (RW) approach for the CI electrode array insertion. Before opening the RW, the eCochG recording electrode is placed on the cochlear promontory, and placed not to obstruct the surgery. The probe is thus maintained during the whole ROBOTIC insertion.

Device: Neuro Cochlear Implant System
Before the mastoidectomy, the ear canal is cleaned, the insert earphone is connected to the Eclipse (Oticon Medical software) preamplifier and placed into the ear canal. The EEG scalp electrodes (active, ground electrode) are placed on the patient's head. After the posterior tympanotomy, the reference electrode (eCochG probe) is placed on the cochlear promontory. The CI electrode array will be inserted following one of the two possible techniques while the eCochG will be recording. The surgeon will either manually insert the array using the Oticon Medical stylet and following the surgery guides and recommendations from Oticon Medical or will control the Robotol insertion angle and drive the robotic arm in the same way.

Outcome Measures

Primary Outcome Measures

  1. Correlation coefficient between the eCochG trauma index (in µV) and the residual hearing (in dB HL). [Through study completion, an average of 2 years]

    The eCochG trauma index correspond to electrophysiological changes of the cochlear response during the CI electrode insertion, and is calculated from the difference between post-insertion and pre-insertion eCochG measure (in µV). The hearing loss is calculated from the difference between the post-surgical and pre-surgical hearing thresholds (in dB HL). The correspondence is calculated from the correlation coefficient between the eCochG trauma index and the hearing loss. It is expected that a potential damage measured by the eCochG during the surgery have affected auditory threshold.

Secondary Outcome Measures

  1. Significant decrease of eCochG trauma index (in µV) for electrode array insertion performed manually compared to robotic. [Through study completion, average of 2 years]

    eCochG trauma index (µV) as a result of manual electrode insertion compared with robotic insertion. Different behaviors of audiological markers since the cochlea may have suffered from biological cell degradation due to the CI electrode insertion. Allied with cochlear degradation will come increased tissue scar density, subsequently increased resistivity of the biological field to the electrical current. This would imply a cascade effect of electrical and audiological outcomes (higher impedances, higher electrical charges required to evoke a sound or the auditory nerve feedback - eCAP, lower overall performances).

  2. Correlation coefficient between the eCochG trauma index (in µV) and a misplacement of the electrode array inside the cochlea based on CT scan. [Through study completion, average of 2 years]

    The misplacement will be quantified with the cochlear coverage (in %) and a subjective assessment of the Eschraghi trauma index for exploratory purpose. eCochG trauma index (µV) with placement of the CI electrode array in the cochlea (using Pre and Post surgical CT scans).

  3. Correlation coefficient between the eCochG trauma index (in nV) with the electrical charges (in nC) required to elicit eCAP threshold. [Through study completion, average of 2 years]

    eCochG trauma index (µV) with eCAP thresholds (nC).

  4. Correlation coefficient between the eCochG trauma index (in nV) with impedance measurement (in Ω). [Through study completion, average of 2 years]

    eCochG trauma index (µV) with CI electrode impedances (Ohm).

  5. Correlation coefficient between the eCochG trauma index (in nV) with fitting map electrical charges (in nC), and slopes of their growth functions. [Through study completion, average of 2 years]

    eCochG trauma index (µV) with electrical charge (nC) measured on the patient CI fitting map.

  6. Correlation coefficient between the eCochG trauma index (in nV) with scores of phonemes discrimination (%). [Through study completion, average of 2 years]

    eCochG trauma index (µV) with scores (in %) of phonemes recognition.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • or equal 18 years ;

  • Candidate for Neuro Zti EVO cochlear implant system, unilateral or bilateral recipient ;

  • Preoperative residual hearing with audiometric thresholds less or equal than 80 dB at 500 Hz, or higher frequencies

Exclusion Criteria:
  • Medical or psychological conditions which contraindicate surgery (e.g middle ear infection, tympanic membrane perforation) ;

  • Patient with a psychological or linguistic inability to understand the information sheet ;

  • Patient under legal protection or deprived of liberty

  • Patient included and participating to another trial.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Oticon Medical

Investigators

  • Principal Investigator: Yann YN Nguyen, Hôpital Pitié-Salpêtrière (Paris)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oticon Medical
ClinicalTrials.gov Identifier:
NCT04651660
Other Study ID Numbers:
  • PIC-22
First Posted:
Dec 3, 2020
Last Update Posted:
Apr 20, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2022